Literature DB >> 23747000

Transcriptional regulation of effector and memory CD8+ T cell fates.

James E D Thaventhiran1, Douglas T Fearon, Luca Gattinoni.   

Abstract

Immunity to intracellular pathogens and cancer relies on the generation of robust CD8(+) T cell effector responses as well as the establishment of immunological memory. During a primary immune response CD8(+) T cells experience diverse extracellular environmental cues and cell-cell interactions that trigger downstream transcriptional programs ultimately guiding a CD8(+) T cell to undertake either an effector or a memory cell fate. Here, we discuss our current understanding of the signaling pathways and transcriptional networks that regulate effector and memory commitment in CD8(+) T lymphocytes. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23747000      PMCID: PMC3766771          DOI: 10.1016/j.coi.2013.05.010

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  65 in total

1.  Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.

Authors:  Hirohito Ichii; Akemi Sakamoto; Masahiko Hatano; Seiji Okada; Hirochika Toyama; Shinsuke Taki; Masafumi Arima; Yoshikazu Kuroda; Takeshi Tokuhisa
Journal:  Nat Immunol       Date:  2002-05-20       Impact factor: 25.606

Review 2.  T cells and viral persistence: lessons from diverse infections.

Authors:  Paul Klenerman; Ann Hill
Journal:  Nat Immunol       Date:  2005-09       Impact factor: 25.606

3.  Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses.

Authors:  Axel Kallies; Annie Xin; Gabrielle T Belz; Stephen L Nutt
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

4.  CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.

Authors:  Joshua J Obar; Michael J Molloy; Evan R Jellison; Thomas A Stoklasek; Weijun Zhang; Edward J Usherwood; Leo Lefrançois
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

5.  Constitutive activation of Wnt signaling favors generation of memory CD8 T cells.

Authors:  Dong-Mei Zhao; Shuyang Yu; Xinyuan Zhou; Jodie S Haring; Werner Held; Vladimir P Badovinac; John T Harty; Hai-Hui Xue
Journal:  J Immunol       Date:  2009-12-21       Impact factor: 5.422

6.  Bcl6 acts as an amplifier for the generation and proliferative capacity of central memory CD8+ T cells.

Authors:  Hirohito Ichii; Akemi Sakamoto; Yoshikazu Kuroda; Takeshi Tokuhisa
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

7.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells.

Authors:  Matthew E Pipkin; Jilian A Sacks; Fernando Cruz-Guilloty; Mathias G Lichtenheld; Michael J Bevan; Anjana Rao
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

8.  Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo.

Authors:  Vandana Kalia; Surojit Sarkar; Shruti Subramaniam; W Nicholas Haining; Kendall A Smith; Rafi Ahmed
Journal:  Immunity       Date:  2010-01-21       Impact factor: 31.745

9.  The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.

Authors:  Rajesh R Rao; Qingsheng Li; Kunle Odunsi; Protul A Shrikant
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

10.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

View more
  18 in total

1.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function.

Authors:  Madhusudhanan Sukumar; Jie Liu; Yun Ji; Murugan Subramanian; Joseph G Crompton; Zhiya Yu; Rahul Roychoudhuri; Douglas C Palmer; Pawel Muranski; Edward D Karoly; Robert P Mohney; Christopher A Klebanoff; Ashish Lal; Toren Finkel; Nicholas P Restifo; Luca Gattinoni
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 2.  Enhancing adoptive T cell immunotherapy with microRNA therapeutics.

Authors:  Yun Ji; James D Hocker; Luca Gattinoni
Journal:  Semin Immunol       Date:  2015-12-20       Impact factor: 11.130

3.  Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.

Authors:  Bryan McQueen; Kelsey Trace; Emily Whitman; Taylor Bedsworth; Amorette Barber
Journal:  Immunology       Date:  2016-01-17       Impact factor: 7.397

4.  The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight.

Authors:  Francine E Garrett-Bakelman; Manjula Darshi; Stefan J Green; Ruben C Gur; Ling Lin; Brandon R Macias; Miles J McKenna; Cem Meydan; Tejaswini Mishra; Jad Nasrini; Brian D Piening; Lindsay F Rizzardi; Kumar Sharma; Jamila H Siamwala; Lynn Taylor; Martha Hotz Vitaterna; Maryam Afkarian; Ebrahim Afshinnekoo; Sara Ahadi; Aditya Ambati; Maneesh Arya; Daniela Bezdan; Colin M Callahan; Songjie Chen; Augustine M K Choi; George E Chlipala; Kévin Contrepois; Marisa Covington; Brian E Crucian; Immaculata De Vivo; David F Dinges; Douglas J Ebert; Jason I Feinberg; Jorge A Gandara; Kerry A George; John Goutsias; George S Grills; Alan R Hargens; Martina Heer; Ryan P Hillary; Andrew N Hoofnagle; Vivian Y H Hook; Garrett Jenkinson; Peng Jiang; Ali Keshavarzian; Steven S Laurie; Brittany Lee-McMullen; Sarah B Lumpkins; Matthew MacKay; Mark G Maienschein-Cline; Ari M Melnick; Tyler M Moore; Kiichi Nakahira; Hemal H Patel; Robert Pietrzyk; Varsha Rao; Rintaro Saito; Denis N Salins; Jan M Schilling; Dorothy D Sears; Caroline K Sheridan; Michael B Stenger; Rakel Tryggvadottir; Alexander E Urban; Tomas Vaisar; Benjamin Van Espen; Jing Zhang; Michael G Ziegler; Sara R Zwart; John B Charles; Craig E Kundrot; Graham B I Scott; Susan M Bailey; Mathias Basner; Andrew P Feinberg; Stuart M C Lee; Christopher E Mason; Emmanuel Mignot; Brinda K Rana; Scott M Smith; Michael P Snyder; Fred W Turek
Journal:  Science       Date:  2019-04-12       Impact factor: 47.728

5.  T cell transgressions: Tales of T cell form and function in diverse disease states.

Authors:  Kevin M Harris; Madison A Clements; Andrew J Kwilasz; Linda R Watkins
Journal:  Int Rev Immunol       Date:  2021-06-21       Impact factor: 5.078

6.  Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFNγ- Thpp cells.

Authors:  Nan Deng; Jason M Weaver; Tim R Mosmann
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

7.  PKC-Theta is a Novel SC35 Splicing Factor Regulator in Response to T Cell Activation.

Authors:  Robert Duncan McCuaig; Jennifer Dunn; Jasmine Li; Antonia Masch; Tobias Knaute; Mike Schutkowski; Johannes Zerweck; Sudha Rao
Journal:  Front Immunol       Date:  2015-11-05       Impact factor: 7.561

8.  Smad4 represses the generation of memory-precursor effector T cells but is required for the differentiation of central memory T cells.

Authors:  J Cao; X Zhang; Q Wang; G Qiu; C Hou; J Wang; Q Cheng; Y Lan; H Han; H Shen; Y Zhang; X Yang; B Shen; J Zhang
Journal:  Cell Death Dis       Date:  2015-11-19       Impact factor: 8.469

9.  Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4+ T cells through p65 and H2B phosphorylation.

Authors:  Jasmine Li; Kristine Hardy; Chan Phetsouphanh; Wen Juan Tu; Elissa L Sutcliffe; Robert McCuaig; Christopher R Sutton; Anjum Zafar; C Mee Ling Munier; John J Zaunders; Yin Xu; Angelo Theodoratos; Abel Tan; Pek Siew Lim; Tobias Knaute; Antonia Masch; Johannes Zerweck; Vedran Brezar; Peter J Milburn; Jenny Dunn; Marco G Casarotto; Stephen J Turner; Nabila Seddiki; Anthony D Kelleher; Sudha Rao
Journal:  J Cell Sci       Date:  2016-05-05       Impact factor: 5.285

10.  Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance.

Authors:  Douglas C Palmer; Geoffrey C Guittard; Zulmarie Franco; Joseph G Crompton; Robert L Eil; Shashank J Patel; Yun Ji; Nicholas Van Panhuys; Christopher A Klebanoff; Madhusudhanan Sukumar; David Clever; Anna Chichura; Rahul Roychoudhuri; Rajat Varma; Ena Wang; Luca Gattinoni; Francesco M Marincola; Lakshmi Balagopalan; Lawrence E Samelson; Nicholas P Restifo
Journal:  J Exp Med       Date:  2015-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.